|Bid||4.1800 x 4000|
|Ask||4.1900 x 3100|
|Day's range||4.1600 - 4.4700|
|52-week range||1.1200 - 6.4700|
|Beta (5Y monthly)||1.91|
|PE ratio (TTM)||N/A|
|Earnings date||29 Oct 2020|
|Forward dividend & yield||N/A (N/A)|
|1y target est||8.00|
One is producing large numbers of COVID-19 diagnostic tests; the other may be among the first companies to get a coronavirus vaccine approved.
Successful partnerships with major sports leagues and updated guidance may mean coronavirus testing is here to stay.
OPKO Health (OPK) closed the most recent trading day at $4.30, moving +1.78% from the previous trading session.